Relative Meaningfulness and Impacts of Symptoms in People with Early-Stage Parkinson’s Disease

Author:

Mammen Jennifer R.1,Speck Rebecca M.2,Stebbins Glenn T.3,Müller Martijn L.T.M.2,Yang Phillip T.4,Campbell Michelle5,Cosman Josh6,Crawford John E.,Dam Tien7,Hellsten Johan8,Jensen-Roberts Stella4,Kostrzebski Melissa49,Simuni Tanya10,Barowicz Kimberly Ward2,Cedarbaum Jesse M.1112,Dorsey E. Ray49,Stephenson Diane2,Adams Jamie L.49

Affiliation:

1. University of Rhode Island, College of Nursing, Providence, RI, USA

2. Critical Path Institute, Tucson, AZ, USA

3. Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA

4. Center for Health + Technology, University of Rochester, Rochester, NY, USA

5. Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, MD, USA

6. Abbvie Inc., North Chicago, IL, USA

7. Biogen, Cambridge, MA, USA

8. H. Lundbeck A/S, Valby, Denmark

9. Department of Neurology, University of Rochester, Rochester, NY, USA

10. Northwestern University Feinberg School of Medicine, Chicago, IL, USA

11. Coeruleus Clinical Sciences LLC, Woodbridge, CT, USA

12. Yale Medical School, New Haven, CT, USA

Abstract

Background: Patient perspectives on meaningful symptoms and impacts in early Parkinson’s disease (PD) are lacking and are urgently needed to clarify priority areas for monitoring, management, and new therapies. Objective: To examine experiences of people with early-stage PD, systematically describe meaningful symptoms and impacts, and determine which are most bothersome or important. Methods: Forty adults with early PD who participated in a study evaluating smartwatch and smartphone digital measures (WATCH-PD study) completed online interviews with symptom mapping to hierarchically delineate symptoms and impacts of disease from “Most bothersome” to “Not present,” and to identify which of these were viewed as most important and why. Individual symptom maps were coded for types, frequencies, and bothersomeness of symptoms and their impacts, with thematic analysis of narratives to explore perceptions. Results: The three most bothersome and important symptoms were tremor, fine motor difficulties, and slow movements. Symptoms had the greatest impact on sleep, job functioning, exercise, communication, relationships, and self-concept— commonly expressed as a sense of being limited by PD. Thematically, most bothersome symptoms were those that were personally limiting with broadest negative impact on well-being and activities. However, symptoms could be important to patients even when not present or limiting (e.g., speech, cognition). Conclusion: Meaningful symptoms of early PD can include symptoms that are present or anticipated future symptoms that are important to the individual. Systematic assessment of meaningful symptoms should aim to assess the extent to which symptoms are personally important, present, bothersome, and limiting

Publisher

IOS Press

Subject

Cellular and Molecular Neuroscience,Neurology (clinical)

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3